Improved LPS-induced pulmonary inflammation resolution, neutrophil apoptosis and downregulation of Mcl-1. Enhanced bacterial clearance in established E. coli pneumonia and accelerated resolution of infection-associated inflammation. Also accelerated resolution of established lipoteichoic acid/peptidoglycan mediated lung inflammation. The gene discussed is MCL1; the disease is inflammation.